A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers

Archives of Surgery

Volumn 137, Issue 7, 2002, Pages 822-827

  Veves, Aristidis ^a   Sheehan, Peter ^b   Pham, Hau T ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULOSE; COLLAGEN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC FOOT; FEMALE; FOOT ULCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TEACHING HOSPITAL; WOUND DRESSING; WOUND HEALING;

EID: 0036307346     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.137.7.822     Document Type: Article

References (25)

1. The epidemiology of lower extremity amputations in diabetic individuals
2. Incidence, outcomes, and cost of foot ulcers in patients with diabetes
3. Costs and duration of care for lower extremity ulcers in patients with diabetes
4. A 4-year outcome-based retrospective study of wound healing and limb salvage in patients with chronic wounds
5. Cost-effective management of diabetic foot ulcers: A review
6. Diabetic foot ulcers in a multidisciplinary setting: An economic analysis of primary healing and healing with amputation
7. Evidence-based options for off-loading diabetic wounds
8. Wound care in diabetic foot ulceration
9. Consensus Development Conference on Diabetic Foot Wound Care: 7-8 April 1999, Boston, Massachusetts
10. Collagen as a pharmacological approach in wound healing
11. Isolation and purification of collagen α 1 (I) receptor from human platelet membrane
12. Fibronectin: Localization in normal human skin, granulation tissue, hypertrophic scar, mature scar, progressive systemic sclerotic skin, and other fibrosing dermatoses
13. Can heterologous collagen enhance the granulation tissue growth? an experimental study
14. Mechanism of action of a next generation wound treatment
15. Cutaneous wound healing
16. General principles of wound healing
17. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds
18. The role of nitric oxide synthase isoforms and arginase in the pathogenesis of diabetic foot ulcers: Possible modulatory effects by transforming growth factor beta 1
19. Cultured fibroblasts from chronic diabetic wounds on the lower extremity (non-insulin-dependent diabetes mellitus) show disturbed proliferation
20. Evaluation of a collagen-alginate topical wound dressing in the management of diabetic foot ulcers
21. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers: A phase III randomized placebo-controlled double-blind study
22. A human dermal replacement for the treatment of diabetic foot ulcers
23. Evaluation of a human skin equivalent (Apligraf), for the treatment of diabetic foot ulcers in a prospective, randomized, clinical trial
24. Effect of extensive debridement and treatment on the healing of diabetic foot ulcers
25. Healing of diabetic neuropathic foot ulcers receiving standard treatment: A meta-analysis